MedTrace Logo

The Relationship Of The Surgical Pleth Index Values With Postoperative Pain Score And Analgesia Consumption

NCT05147714 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2021-12-07

No results posted yet for this study

Summary

Postoperative pain management has an important role in anesthesia practice. In order to ensure postoperative patient comfort, postoperative rehabilitation should start early and be managed effectively1. It is known that if adequate analgesia is not provided before the patient wakes up, the severity of pain and the total opioid consumption increases. This increased opioid use causes complications such as nausea, vomiting, constipation, increased sleepiness and respiratory depression2. For this reason, the provision of adequate analgesia before the patient is awakened from general anesthesia has an important place in the process. Measurement of pain has different characteristics in patients under sedation or general anesthesia compared to conscious patients. However, since it is not possible for the patient to define pain under general anesthesia, different measurement and evaluation methods are needed. In order to monitor the intraoperative balance between nociception and antinociception, several non-invasive methods with different physiological approaches have been researched and made available for use in the last decade. The aim of these methods is individualize the intraoperative and postoperative opioid dose3. In this context, it has been suggested that the Surgical Pleth Index (SPI) method can be used in the evaluation of the analgesic component of anesthesia.

Conditions

  • Acute Pain
  • Analgesia

Interventions

DEVICE

Surgical Pleth Index (SPI)

SPI data were recorded at one-minute intervals during the last five minutes (6 times in total) until the entropy value reached 60

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Mukadder Orhan Sungur, Prof. · Istanbul University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-06-01
Completion
2021-11-08

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05147714 on ClinicalTrials.gov